Clinical and Microbiological Spectra and Therapeutic Outcomes of Polymicrobial Keratitis

Anubha Rathi1, Khuraman Ramazanova1, Somasheila I Murthy1

  • 1The Cornea Institute, LV Prasad Eye Institute, Hyderabad, India.

Cornea
|August 15, 2022
PubMed
Abstract

Insights

Polymicrobial keratitis (PMK) is rare and often involves bacterial and fungal infections, leading to poor outcomes with medical treatment alone. Early surgical intervention is recommended for better results in these complex cases.

Area of Science:

  • Ophthalmology
  • Infectious Diseases
  • Microbiology

Background:

  • Polymicrobial keratitis (PMK) is a severe eye infection involving multiple microorganisms.
  • Understanding its risk factors, microbial profile, and treatment outcomes is crucial for effective management.

Purpose of the Study:

  • To evaluate the risk factors, microbiology, and treatment outcomes of polymicrobial keratitis (PMK).

Main Methods:

  • Retrospective analysis of 65 patients diagnosed with PMK between 2016 and 2019.
  • Evaluation of clinical and microbiological characteristics, treatment strategies, and outcomes.
  • Categorization of outcomes into absolute success, qualified success, and failure based on infection resolution and need for surgical intervention.

Main Results:

  • PMK accounted for 1.36% of microbial keratitis cases.
  • Bacterial and fungal co-infection was predominant (95%), with high fluoroquinolone resistance (57%).
  • Treatment failure occurred in 55% of cases, with predisposing factors including trauma and uncontrolled diabetes; visual acuity was significantly worse in treatment failure groups.

Conclusions:

  • PMK is a rare but challenging condition with a high rate of treatment failure under medical management alone.
  • The predominant bacterial and fungal etiology necessitates consideration of combined therapeutic approaches.
  • Early surgical intervention is advocated to improve overall outcomes in polymicrobial keratitis.